DK0915841T3 - Anilinopeptidderivater - Google Patents

Anilinopeptidderivater

Info

Publication number
DK0915841T3
DK0915841T3 DK97934472T DK97934472T DK0915841T3 DK 0915841 T3 DK0915841 T3 DK 0915841T3 DK 97934472 T DK97934472 T DK 97934472T DK 97934472 T DK97934472 T DK 97934472T DK 0915841 T3 DK0915841 T3 DK 0915841T3
Authority
DK
Denmark
Prior art keywords
lower alkyl
independently
triazol
salt
compounds
Prior art date
Application number
DK97934472T
Other languages
Danish (da)
English (en)
Inventor
Alexander Faessler
Guido Bold
Hans-Georg Capraro
Marc Lang
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0915841T3 publication Critical patent/DK0915841T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97934472T 1996-07-17 1997-07-16 Anilinopeptidderivater DK0915841T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH178896 1996-07-17
PCT/EP1997/003804 WO1998003476A1 (en) 1996-07-17 1997-07-16 Anilinopeptide derivatives

Publications (1)

Publication Number Publication Date
DK0915841T3 true DK0915841T3 (da) 2002-06-10

Family

ID=4218620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97934472T DK0915841T3 (da) 1996-07-17 1997-07-16 Anilinopeptidderivater

Country Status (10)

Country Link
US (1) US6451973B1 (pt)
EP (1) EP0915841B1 (pt)
JP (1) JP4100710B2 (pt)
AT (1) ATE213725T1 (pt)
AU (1) AU3767797A (pt)
DE (1) DE69710731T2 (pt)
DK (1) DK0915841T3 (pt)
ES (1) ES2173466T3 (pt)
PT (1) PT915841E (pt)
WO (1) WO1998003476A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2173466T3 (es) * 1996-07-17 2002-10-16 Novartis Ag Derivados de anilinopeptido
NZ533282A (en) 2001-12-05 2006-09-29 Ortho Mcneil Pharm Inc 6-O-Acyl ketolide derivatives of erythromycine useful as antibacterials
ATE539074T1 (de) * 2003-12-11 2012-01-15 Abbott Lab Die hiv-protease hemmende verbindungen
EP1697348B1 (en) * 2003-12-11 2011-12-28 Abbott Laboratories Hiv protease inhibiting compounds
US7723380B2 (en) 2006-07-21 2010-05-25 Gilead Sciences, Inc. Antiviral protease inhibitors
WO2011080562A1 (en) 2009-12-29 2011-07-07 Hetero Research Foundation Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals
JOP20180009A1 (ar) 2017-02-06 2019-01-30 Gilead Sciences Inc مركبات مثبط فيروس hiv
TWI766172B (zh) 2018-07-30 2022-06-01 美商基利科學股份有限公司 抗hiv化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556654A (en) 1983-06-28 1985-12-03 Warner-Lambert Company Antimicrobial substituted anthra[1,9-cd]pyrazol-6(2H)-ones
IE913840A1 (en) 1990-11-20 1992-05-20 Abbott Lab Retroviral protease inhibiting compounds
US5753652A (en) * 1991-07-03 1998-05-19 Novartis Corporation Antiretroviral hydrazine derivatives
RU2126794C1 (ru) 1992-03-11 1999-02-27 Нархекс Лимитед Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы
DK0604368T3 (pt) 1992-12-23 1997-02-24 Ciba Geigy Ag
KR100333016B1 (ko) 1992-12-29 2002-11-22 아보트 러보러터리즈 레트로바이러스성프로테아제억제화합물,이의제조방법및이를함유하는약제학적조성물
US5461067A (en) 1993-02-25 1995-10-24 Abbott Laboratories Retroviral protease inhibiting compounds
ES2180600T3 (es) 1994-10-19 2003-02-16 Novartis Ag Eteres de isosteros substrato de aspartato proteasa antivirales.
US5849911A (en) * 1996-04-22 1998-12-15 Novartis Finance Corporation Antivirally active heterocyclic azahexane derivatives
ES2173466T3 (es) * 1996-07-17 2002-10-16 Novartis Ag Derivados de anilinopeptido

Also Published As

Publication number Publication date
WO1998003476A1 (en) 1998-01-29
DE69710731T2 (de) 2002-10-24
ES2173466T3 (es) 2002-10-16
AU3767797A (en) 1998-02-10
EP0915841B1 (en) 2002-02-27
PT915841E (pt) 2002-08-30
DE69710731D1 (de) 2002-04-04
US6451973B1 (en) 2002-09-17
ATE213725T1 (de) 2002-03-15
JP4100710B2 (ja) 2008-06-11
JP2000515147A (ja) 2000-11-14
EP0915841A1 (en) 1999-05-19

Similar Documents

Publication Publication Date Title
DE69402173T2 (de) Hemmung von Thrombin
DK0558673T3 (da) Retrovirale proteaseinhibitorer
MY108885A (en) Heterocyclic-cyclic amine derivatives.
UA26930C2 (uk) Засіб для іhгібуваhhя еhдометріозу
ATE155779T1 (de) Retrovirale protease-inhibitoren
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
DE69402165T2 (de) Hemmung von Seborrhoe und Akne
ATE260104T1 (de) Hemmung der endprodukte fortgeschrittener glykolisierung
NO943874L (no) Behandling av resistant neoplasma
DE69710731T2 (de) Anilinopeptid-derivate
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
DE69427807D1 (de) Hemmung von Hirsutismus und Alopecia bei Frauen
NO942668L (no) Alkylderivater av trazodon med CNS-aktivitet